Market Place
Sourcing Support
All News #Library
Biotech
Aslan’s dream of challenging Dupixent dies as cash-strapped biotech winds down
17 Jul 2024 //
FIERCE BIOTECH
ASLAN Presents Eblasakimab COPD Translational Data At ATS
21 May 2024 //
GLOBENEWSWIRE
ASLAN Pharma Q1 2024 Financials And Corporate Update
09 May 2024 //
GLOBENEWSWIRE
ASLAN On Eblasakimab Data In Atopic Dermatitis From TREK-DX Study
07 May 2024 //
GLOBENEWSWIRE
ASLAN KOL Panel on AD Treatment Options Post-Dupilumab
30 Apr 2024 //
GLOBENEWSWIRE
ASLAN`s Eblasakimab COPD Abstract at ATS Conference
24 Apr 2024 //
GLOBENEWSWIRE
ASLAN`s Eblasakimab Positive Interim Atopic Dermatitis Data
22 Apr 2024 //
GLOBENEWSWIRE
ASLAN Pharmaceuticals Announces New Translational Data on Eblasakimab
06 Mar 2024 //
GLOBENEWSWIRE
ASLAN Provides Year-End Update on Its Eblasakimab and Farudodstat Programs
12 Dec 2023 //
GLOBENEWSWIRE
ASLAN Pharmaceuticals Presents New Data on Eblasakimab in Atopic Dermatitis
03 Nov 2023 //
GLOBENEWSWIRE
ASLAN Pharmaceuticals Reports Third Quarter 2023 Financial Results
27 Oct 2023 //
GLOBENEWSWIRE
ASLAN Pharmaceuticals Presents New Data From Phase 2b Study of Eblasakimab
13 Oct 2023 //
GLOBENEWSWIRE
ASLAN Announces Acceptance of Late Breaker Abstract on Eblasakimab Ph 2b Results
22 Sep 2023 //
GLOBENEWSWIRE
ASLAN Pharmaceuticals Reports Second Quarter 2023 Financial Results
11 Aug 2023 //
GLOBENEWSWIRE
ASLAN Announces Publication in Clinical Immunology Highlighting Eblasakimab
23 Jun 2023 //
GLOBENEWSWIRE
ASLAN Pharmaceuticals Presents New Data on Eblasakimab and Farudodstat
15 May 2023 //
GLOBENEWSWIRE
ASLAN Announces Four Abstracts on Eblasakimab and Farudodstat
24 Apr 2023 //
GLOBENEWSWIRE
ASLAN Announces Completion of Recruitment in P2b TREK-AD Study of Eblasakimab
24 Feb 2023 //
GLOBENEWSWIRE
ASLAN Pharma and Thermo Fisher Scientific Announce Partnership
03 Jan 2023 //
GLOBENEWSWIRE
Aslan, Thermo Fisher Ink Clinical Manufacturing Deal
03 Jan 2023 //
CONTRACT PHARMA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.